Estradiol valerate/medroxyprogesterone

Drug Profile

Estradiol valerate/medroxyprogesterone

Alternative Names: Duova; Estradiol/medroxyprogesterone acetate - Orion Pharma; Indivina

Latest Information Update: 24 Jan 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Orion
  • Class Estradiol congeners; Estrenes; Hormonal replacements; Pregnenediones
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Menopausal syndrome; Postmenopausal osteoporosis

Most Recent Events

  • 09 Jan 2001 Launched for Menopausal syndrome in United Kingdom (PO)
  • 09 Jan 2001 Launched for Postmenopausal osteoporosis prevention in United Kingdom (PO)
  • 01 Dec 2000 Launched for Menopausal syndrome in European Union (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top